首页 > 最新文献

Implementation Science最新文献

英文 中文
Improving measurement-based care implementation in youth mental health through organizational leadership and climate: a mechanistic analysis within a randomized trial 通过组织领导力和氛围改善青少年心理健康中基于测量的护理实施:随机试验中的机制分析
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-28 DOI: 10.1186/s13012-024-01356-w
Nathaniel J. Williams, Mark G. Ehrhart, Gregory A. Aarons, Susan Esp, Marisa Sklar, Kristine Carandang, Nallely R. Vega, Lauren Brookman-Frazee, Steven C. Marcus
Theory and correlational research indicate organizational leadership and climate are important for successful implementation of evidence-based practices (EBPs) in healthcare settings; however, experimental evidence is lacking. We addressed this gap using data from the WISDOM (Working to Implement and Sustain Digital Outcome Measures) hybrid type III effectiveness-implementation trial. Primary outcomes from WISDOM indicated the Leadership and Organizational Change for Implementation (LOCI) strategy improved fidelity to measurement-based care (MBC) in youth mental health services. In this study, we tested LOCI’s hypothesized mechanisms of change, namely: (1) LOCI will improve implementation and transformational leadership, which in turn will (2) mediate LOCI’s effect on implementation climate, which in turn will (3) mediate LOCI’s effect on MBC fidelity. Twenty-one outpatient mental health clinics serving youth were randomly assigned to LOCI plus MBC training and technical assistance or MBC training and technical assistance only. Clinicians rated their leaders’ implementation leadership, transformational leadership, and clinic implementation climate for MBC at five time points (baseline, 4-, 8-, 12-, and 18-months post-baseline). MBC fidelity was assessed using electronic metadata for youth outpatients who initiated treatment in the 12 months following MBC training. Hypotheses were tested using longitudinal mixed-effects models and multilevel mediation analyses. LOCI significantly improved implementation leadership and implementation climate from baseline to follow-up at 4-, 8-, 12-, and 18-month post-baseline (all ps < .01), producing large effects (range of ds = 0.76 to 1.34). LOCI’s effects on transformational leadership were small at 4 months (d = 0.31, p = .019) and nonsignificant thereafter (ps > .05). LOCI’s improvement of clinic implementation climate from baseline to 12 months was mediated by improvement in implementation leadership from baseline to 4 months (proportion mediated [pm] = 0.82, p = .004). Transformational leadership did not mediate LOCI’s effect on implementation climate (p = 0.136). Improvement in clinic implementation climate from baseline to 12 months mediated LOCI’s effect on MBC fidelity during the same period (pm = 0.71, p = .045). LOCI improved MBC fidelity in youth mental health services by improving clinic implementation climate, which was itself improved by increased implementation leadership. Fidelity to EBPs in healthcare settings can be improved by developing organizational leaders and strong implementation climates. ClinicalTrials.gov identifier: NCT04096274. Registered September 18, 2019.
理论和相关研究表明,组织领导力和氛围对于在医疗机构成功实施循证实践(EBPs)非常重要;然而,目前还缺乏实验证据。我们利用 WISDOM(努力实施和维持数字化成果措施)混合 III 型有效性实施试验的数据填补了这一空白。WISDOM 的主要结果表明,领导力和组织变革促进实施(LOCI)策略提高了青少年心理健康服务中基于测量的护理(MBC)的忠实度。在这项研究中,我们测试了 LOCI 假设的变革机制,即:(1)LOCI 将改善实施和变革领导力,进而(2)LOCI 对实施氛围的影响,进而(3)LOCI 对 MBC 忠实度的影响。21 家为青少年服务的门诊心理健康诊所被随机分配到 LOCI 加 MBC 培训和技术援助或仅 MBC 培训和技术援助。临床医生在五个时间点(基线、基线后 4 个月、8 个月、12 个月和 18 个月)对其领导者的 MBC 实施领导力、变革领导力和诊所实施氛围进行评分。对 MBC 培训后 12 个月内开始治疗的青年门诊患者的电子元数据进行了 MBC 忠实度评估。使用纵向混合效应模型和多层次中介分析对假设进行了检验。在基线后 4 个月、8 个月、12 个月和 18 个月的随访中,LOCI 明显改善了实施领导力和实施氛围(所有 ps 均为 0.05)。LOCI 对诊所实施氛围从基线到 12 个月的改善是由实施领导力从基线到 4 个月的改善所中介的(中介比例 [pm] = 0.82,P = .004)。变革型领导对 LOCI 对实施氛围的影响没有中介作用(p = 0.136)。从基线到 12 个月期间,诊所实施氛围的改善对 LOCI 对同期 MBC 忠实度的影响起到了中介作用(pm = 0.71,p = 0.045)。LOCI 通过改善诊所的实施氛围提高了青少年心理健康服务的 MBC 忠实度,而实施领导力的提高又改善了诊所的实施氛围。通过培养组织领导者和营造浓厚的实施氛围,可以提高医疗机构对 EBPs 的忠实度。ClinicalTrials.gov identifier:NCT04096274。注册时间:2019 年 9 月 18 日。
{"title":"Improving measurement-based care implementation in youth mental health through organizational leadership and climate: a mechanistic analysis within a randomized trial","authors":"Nathaniel J. Williams, Mark G. Ehrhart, Gregory A. Aarons, Susan Esp, Marisa Sklar, Kristine Carandang, Nallely R. Vega, Lauren Brookman-Frazee, Steven C. Marcus","doi":"10.1186/s13012-024-01356-w","DOIUrl":"https://doi.org/10.1186/s13012-024-01356-w","url":null,"abstract":"Theory and correlational research indicate organizational leadership and climate are important for successful implementation of evidence-based practices (EBPs) in healthcare settings; however, experimental evidence is lacking. We addressed this gap using data from the WISDOM (Working to Implement and Sustain Digital Outcome Measures) hybrid type III effectiveness-implementation trial. Primary outcomes from WISDOM indicated the Leadership and Organizational Change for Implementation (LOCI) strategy improved fidelity to measurement-based care (MBC) in youth mental health services. In this study, we tested LOCI’s hypothesized mechanisms of change, namely: (1) LOCI will improve implementation and transformational leadership, which in turn will (2) mediate LOCI’s effect on implementation climate, which in turn will (3) mediate LOCI’s effect on MBC fidelity. Twenty-one outpatient mental health clinics serving youth were randomly assigned to LOCI plus MBC training and technical assistance or MBC training and technical assistance only. Clinicians rated their leaders’ implementation leadership, transformational leadership, and clinic implementation climate for MBC at five time points (baseline, 4-, 8-, 12-, and 18-months post-baseline). MBC fidelity was assessed using electronic metadata for youth outpatients who initiated treatment in the 12 months following MBC training. Hypotheses were tested using longitudinal mixed-effects models and multilevel mediation analyses. LOCI significantly improved implementation leadership and implementation climate from baseline to follow-up at 4-, 8-, 12-, and 18-month post-baseline (all ps < .01), producing large effects (range of ds = 0.76 to 1.34). LOCI’s effects on transformational leadership were small at 4 months (d = 0.31, p = .019) and nonsignificant thereafter (ps > .05). LOCI’s improvement of clinic implementation climate from baseline to 12 months was mediated by improvement in implementation leadership from baseline to 4 months (proportion mediated [pm] = 0.82, p = .004). Transformational leadership did not mediate LOCI’s effect on implementation climate (p = 0.136). Improvement in clinic implementation climate from baseline to 12 months mediated LOCI’s effect on MBC fidelity during the same period (pm = 0.71, p = .045). LOCI improved MBC fidelity in youth mental health services by improving clinic implementation climate, which was itself improved by increased implementation leadership. Fidelity to EBPs in healthcare settings can be improved by developing organizational leaders and strong implementation climates. ClinicalTrials.gov identifier: NCT04096274. Registered September 18, 2019.","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"6 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140312267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proceedings of the 6th UK and Ireland implementation science research conference 第六届英国和爱尔兰实施科学研究会议论文集
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-20 DOI: 10.1186/s13012-024-01341-3
<p><i>Sustaining Health and Public Services in an Uncertain Future: What Role for Implementation Science?</i></p><p><b>Institute of Psychiatry, Psychology and Neuroscience, King's College London & University of Limerick</b></p><h3>Carmel Davies<sup>1</sup>, Deirdre O’Donnell<sup>1</sup>, Apolonia Radomska<sup>1</sup>, Éidín Ní Shé<sup>3</sup>, Marie O’Shea<sup>1</sup>, Catherine Devaney<sup>2</sup>, Sarah Donnelly<sup>1</sup>, Gráinne O’Donoghue<sup>1</sup>, Aoife De Brún<sup>1</sup>, Helen Whitty<sup>2</sup>, PJ Harnett<sup>2</sup>, Deirdre Lang<sup>2</sup>, Reema Harrison<sup>4</sup>, Eilish McAuliffe<sup>1</sup>, Emer Ahern<sup>2</sup></h3><h4><sup>1</sup>University College Dublin, Dublin 4, Ireland; <sup>2</sup>National Clinical Programme for Older Persons, Dublin, Ireland; <sup>3</sup>Royal College of Surgeons of Ireland, Dublin, Ireland; <sup>4</sup>Macquarie University, Sydney, Australia</h4><h5><b>Correspondence:</b> Carmel Davies (carmel.davies@ucd.ie)</h5><p><i>Implementation Science 2024</i>, <b>19(1)</b>:P1</p><br/><p><b>Background</b></p><p>Within global healthcare policy, interprofessional integrated models of care are integral to quality healthcare for older people yet are challenging to implement [1,2,3]. Evidence to guide implementation remains underdeveloped [4]. Drawing on international research evidence, this review identifies interventions to promote effective interprofessional collaboration for improving care for older people. Healthcare implementation is complex and influenced by context, explaining why an intervention might work in one place and not another. Realist approaches explain ‘how’ complex interventions work through dynamic interactions between context, mechanisms, and outcomes [5].</p><p><b>Methods</b></p><p>The review follows the reporting standards of realist reviews [6]. A systematic search in PubMed, CINAHL, PsycINFO, EMBASE and SCOPUS identified primary research studies from 2013-2023. Data were extracted from the theory of interprofessional collaboration in community for older people. Context, interventions, outcomes, and mechanisms were identified and developed into Programme Theories (PTs).</p><p><b>Results</b></p><p>A suite of PTs in the form of Context Mechanism and Outcomes (CMOs) and Resource (R) configurations are presented with the following as an example:</p><p>Where CST members have professional experience in different areas of service delivery (C), they bring to the team pre-existing relationships with other HCPs (R), enabling good cross sectoral communication and trust (M), leading to enhanced continuity of care (O).</p><p><b>Conclusion</b></p><p>The paper explains what interventions work to support interprofessional collaboration and integrated care for older people. It provides a roadmap for implementation planning to help workforce planning and capacity building to improve older people’s health services. The realist synthesis is the first phase of a larger realist evaluatio
方法社区参与和共同设计是实施过程的核心。这是一项基于 "实施科学 "和 "参与式行动研究 "原则的混合方法评估。定量测量包括高血压病例发现、糖尿病前期的识别以及血压和 HbA1c 控制的改善。定性实施评估采用传统实施科学与快速定性评估相结合的方法,使用斯坦福闪电报告法[3]探索影响实施的背景因素,并评估实施的忠实性、适当性和可行性。结果第一次活动于 2023 年 2 月举行,参加活动的 103 人中有 61% 的人血压异常,有两人随后被诊断为 2 型糖尿病。社区认为此次活动非常有用。初步分析表明,良好的社区和利益相关者参与以及获得资金是促进实施的主要因素。结论:健康检查活动成功地响应了社区的健康需求,开发并实施了基于社区的共同设计方法。初步数据显示了该方法的实用性及其提高贫困社区居民参与度的潜力;然而,系统层面的障碍仍然是该干预措施可持续发展的重大挑战:不适用同意发表:参考文献1.City of Bradford Metropolitan District Council.联合战略需求评估,布拉德福德地区人口。布拉德福德。2022.Available from: https://jsna.bradford.gov.uk/documents/The%20population%20of%20Bradford%20District/1.2%20Health%20Inequalities%20and%20Life%20Expectancy/Health%20Inequalities%20and%20life%20expectancy.pdf date accessed 18th July 2022.2.Bradford's Healthy Hearts: better management of CVD patients [Internet].GOV.UK.Available from: https://www.gov.uk/government/case-studies/bradfords-healthy-hearts-better-management-of-cvd-patients3.Brown-Johnson C, Safaeinili N, Zionts D, Holdsworth LM, Shaw JG, Asch SM, Mahoney M, Winget M. The Stanford Lightning Report Method: a comparison of rapid qualitative synthesis results across four implementation evaluations.学习健康系统》。2020 Apr;4(2):e10210.Laura-Jane McCarthy1, Fiona Riordan1, Jane Murphy1, Nickola Pallin1, Claire Kerins2, Bianca Albers3, Lauren Clack3, Eimear Morrissey4, Geoffrey M. Curran5, Cara C. Lewis6, Byron J. Powell7, Justin Presseau8, Luke Wolfenden9, Sheena M. McHugh11公共卫生学院。McHugh11School of Public Health, University College Cork, Cork, Ireland; 2Health Promotion, University of Galway, Galway, Ireland; 3Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland; 4School of Psychology, University of Galway, Galway, Ireland;5Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 6Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA, 98101, USA; 7Brown School, Washington University in St.7Brown School, Washington University in St. Louis, One Brookings Drive, Campus Box 1196, St. Louis, MO, 63130, USA; 8Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Canada; 9School of Medicine and Public Health, College of Health, Medicine, and Wellbeing, the University of Newcastle, Callaghan, NSW, AustraliaCorrespondence:Laura-Jane McCarthy (laura-janemccarthy@ucc.ie)《实施科学 2024》,19(1):P15背景针对实施过程中的突出障碍和促进因素制定策略被认为对支持循证医疗干预措施(EBI)的成功实施和吸收非常重要。我们正在进行一项范围综述,以探讨在医疗保健背景下如何对定制进行概念化、操作化和评估。我们对如何量身定制患者层面的策略以支持循证医疗干预(如筛查干预)的采用了解有限;这延伸到了文化量身定制,即考虑反映患者偏好和需求的文化、语言和当地因素[1]。如何以及何时将患者纳入定制过程也尚不明确。为了弥补这一不足,我们将进行一项子分析,重点关注针对患者的量身定制策略。方法范围界定综述根据最佳实践指南[2]进行,并将按照范围界定综述的系统综述和荟萃分析首选报告项目扩展版(PRISMA-ScR)进行报告。我们对 2005 年至今的 MEDLINE、Embase、Web of Science 和 Scopus 进行了检索。 在辅导过程中培养主人翁精神可提高以康复为导向的干预措施的成功率,但领导层的转变可能具有挑战性。参与成功的实施可以在个人和集体层面启动变革遗产。目前正在与包括原住民和 LGBTQ+ 社区在内的值得公平对待的群体合作,以提高文化包容性。计划在国际卫生和社会保健领域推广:同意发表:同意发表:不适用Hassan1,2、Lucy Melville-Richards3、Adele Ring1,2、Jane Cloke1,2、Sandra Smith2、Pooja Saini4、Mark Goodall1,2、Ana Porroche-Escudero5、Jenn
{"title":"Proceedings of the 6th UK and Ireland implementation science research conference","authors":"","doi":"10.1186/s13012-024-01341-3","DOIUrl":"https://doi.org/10.1186/s13012-024-01341-3","url":null,"abstract":"&lt;p&gt;\u0000&lt;i&gt;Sustaining Health and Public Services in an Uncertain Future: What Role for Implementation Science?&lt;/i&gt;\u0000&lt;/p&gt;&lt;p&gt;\u0000&lt;b&gt;Institute of Psychiatry, Psychology and Neuroscience, King's College London &amp; University of Limerick&lt;/b&gt;\u0000&lt;/p&gt;&lt;h3&gt;Carmel Davies&lt;sup&gt;1&lt;/sup&gt;, Deirdre O’Donnell&lt;sup&gt;1&lt;/sup&gt;, Apolonia Radomska&lt;sup&gt;1&lt;/sup&gt;, Éidín Ní Shé&lt;sup&gt;3&lt;/sup&gt;, Marie O’Shea&lt;sup&gt;1&lt;/sup&gt;, Catherine Devaney&lt;sup&gt;2&lt;/sup&gt;, Sarah Donnelly&lt;sup&gt;1&lt;/sup&gt;, Gráinne O’Donoghue&lt;sup&gt;1&lt;/sup&gt;, Aoife De Brún&lt;sup&gt;1&lt;/sup&gt;, Helen Whitty&lt;sup&gt;2&lt;/sup&gt;, PJ Harnett&lt;sup&gt;2&lt;/sup&gt;, Deirdre Lang&lt;sup&gt;2&lt;/sup&gt;, Reema Harrison&lt;sup&gt;4&lt;/sup&gt;, Eilish McAuliffe&lt;sup&gt;1&lt;/sup&gt;, Emer Ahern&lt;sup&gt;2&lt;/sup&gt;\u0000&lt;/h3&gt;&lt;h4&gt;\u0000&lt;sup&gt;1&lt;/sup&gt;University College Dublin, Dublin 4, Ireland; &lt;sup&gt;2&lt;/sup&gt;National Clinical Programme for Older Persons, Dublin, Ireland; &lt;sup&gt;3&lt;/sup&gt;Royal College of Surgeons of Ireland, Dublin, Ireland; &lt;sup&gt;4&lt;/sup&gt;Macquarie University, Sydney, Australia&lt;/h4&gt;&lt;h5&gt;\u0000&lt;b&gt;Correspondence:&lt;/b&gt; Carmel Davies (carmel.davies@ucd.ie)&lt;/h5&gt;&lt;p&gt;&lt;i&gt;Implementation Science 2024&lt;/i&gt;, &lt;b&gt;19(1)&lt;/b&gt;:P1&lt;/p&gt;&lt;br/&gt;&lt;p&gt;\u0000&lt;b&gt;Background&lt;/b&gt;\u0000&lt;/p&gt;&lt;p&gt;Within global healthcare policy, interprofessional integrated models of care are integral to quality healthcare for older people yet are challenging to implement [1,2,3]. Evidence to guide implementation remains underdeveloped [4]. Drawing on international research evidence, this review identifies interventions to promote effective interprofessional collaboration for improving care for older people. Healthcare implementation is complex and influenced by context, explaining why an intervention might work in one place and not another. Realist approaches explain ‘how’ complex interventions work through dynamic interactions between context, mechanisms, and outcomes [5].&lt;/p&gt;&lt;p&gt;\u0000&lt;b&gt;Methods&lt;/b&gt;\u0000&lt;/p&gt;&lt;p&gt;The review follows the reporting standards of realist reviews [6]. A systematic search in PubMed, CINAHL, PsycINFO, EMBASE and SCOPUS identified primary research studies from 2013-2023. Data were extracted from the theory of interprofessional collaboration in community for older people. Context, interventions, outcomes, and mechanisms were identified and developed into Programme Theories (PTs).&lt;/p&gt;&lt;p&gt;\u0000&lt;b&gt;Results&lt;/b&gt;\u0000&lt;/p&gt;&lt;p&gt;A suite of PTs in the form of Context Mechanism and Outcomes (CMOs) and Resource (R) configurations are presented with the following as an example:&lt;/p&gt;&lt;p&gt;Where CST members have professional experience in different areas of service delivery (C), they bring to the team pre-existing relationships with other HCPs (R), enabling good cross sectoral communication and trust (M), leading to enhanced continuity of care (O).&lt;/p&gt;&lt;p&gt;\u0000&lt;b&gt;Conclusion&lt;/b&gt;\u0000&lt;/p&gt;&lt;p&gt;The paper explains what interventions work to support interprofessional collaboration and integrated care for older people. It provides a roadmap for implementation planning to help workforce planning and capacity building to improve older people’s health services. The realist synthesis is the first phase of a larger realist evaluatio","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"17 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140169112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis 更正:评估公共资金对缓解台湾美沙酮维持治疗诊所参与者减少和提高维持率的影响:间断时间序列分析
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-19 DOI: 10.1186/s13012-024-01358-8
Yu-Chu Ella Chung, Yu-Chi Tung, Sheng-Chang Wang, Chieh-Liang Huang, Lian-Yu Chen, Wei J. Chen
<p><b>Correction</b><b>: </b><b>Implement Sci 19, 18 (2024)</b></p><p><b>https://doi.org/10.1186/s13012-024-01351-1</b></p><p>Following the publication of the original article [1], the authors reported errors in Figure 1 and in a line of Page 3. In the original article, Figure 1 is shown as below.</p><figure><picture><source srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figa_HTML.png?as=webp" type="image/webp"/><img alt="figure a" aria-describedby="Figa" height="632" loading="lazy" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figa_HTML.png" width="685"/></picture></figure><p>There was an error with regard to the Large number (150-700); as it should have been (151-700).</p><p>Thus, the correct Figure 1 is shown below:</p><figure><picture><source srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figb_HTML.png?as=webp" type="image/webp"/><img alt="figure b" aria-describedby="Figb" height="629" loading="lazy" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figb_HTML.png" width="685"/></picture></figure><p>Another error was also found on Page 3 of the Original Article. The second sentence of the second paragraph of the <i>Context of the MMT policy intervention</i> section was read “For MMT clinics with larger capacities that were not eligible for the MCAM, we designated their scale as “large”, i.e., monthly average number of daily participants of 150 to 700.”</p><p>The correct sentence is: For MMT clinics with larger capacities that were not eligible for the MCAM, we designated their scale as “large”, i.e., monthly average number of daily participants of 151 to 700.</p><p>The original article [1] has been updated.</p><ol data-track-component="outbound reference"><li data-counter="1."><p>Chung YCE, Tung YC, Wang SC, et al. Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis. Implement Sci. 2024;19:18. https://doi.org/10.1186/s13012-024-01351-1.</p><p>Article PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-download-medium" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></p><h3>Authors and Affiliations</h3><ol><li><p>Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan</p><p>Yu-Chu Ella Chung, Sheng-Chang Wang & Wei J. Chen</p></li><li><p>Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan</p><p>Yu-Chi Tung</p></li><li><p>Tsaotun Psychiatric Center, Ministry of Health
更正:Implement Sci 19, 18 (2024)https://doi.org/10.1186/s13012-024-01351-1Following 原文[1]发表后,作者报告了图 1 和第 3 页一行中的错误。在原文中,图 1 如下所示。大号(150-700)有误,应为(151-700)。因此,正确的图 1 如下所示:原文第 3 页还发现了另一处错误。在 "MMT 政策干预的背景 "部分的第二段第二句中,"对于不符合 MCAM 条件的较大规模的 MMT 诊所,我们将其规模定为'大型',即每月平均每日参与者人数为 150 至 700 人。"正确的句子是:"对于不符合 MCAM 条件的较大规模的 MMT 诊所,我们将其规模定为'大型',即每月平均每日参与者人数为 150 至 700 人:Chung YCE, Tung YC, Wang SC, et al. Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis.Implement Sci. 2024;19:18. https://doi.org/10.1186/s13012-024-01351-1.Article PubMed PubMed Central Google Scholar Download references作者与单位台湾苗栗国立卫生研究院神经精神研究中心钟玉珠、王胜昌& Wei J. Chen卫生政策与管理研究所。Chen台湾大学公共卫生学院卫生政策与管理研究所,台北,台湾董玉芝台湾卫生福利部南投县草屯精神医学中心,台北,台湾黄志良台湾卫生福利部精神卫生署,台北,台湾陈连玉台湾大学公共卫生学院流行病与预防医学研究所,台北,台湾陈连玉 & Wei J. Chen台湾大学公共卫生学院公共卫生学系,台北,台湾陳國立臺灣大學公共衛生學院公共衛生學系陳國立臺灣大學醫學院暨臺灣大學醫院精神醫學系Wei J. ChenChenAuthorsYu-Chu Ella ChungView Author publications您也可以在PubMed Google Scholar中搜索该作者Yu-Chi TungView Author publications您也可以在PubMed Google Scholar中搜索该作者Sheng-Chang WangView Author publications您也可以在PubMed Google Scholar中搜索该作者Chieh-Liang HuangView Author publications您也可以在PubMed Google Scholar中搜索该作者Lian-Yu ChenView Author publications您也可以在PubMed Google Scholar中搜索该作者Wei J. ChenView Author publications您也可以在PubMed Google Scholar中搜索该作者Wei J. ChenView Author publications您也可以在PubMed Google Scholar中搜索该作者Wei J. ChenView Author publications您也可以在PubMed Google Scholar中搜索该作者Chen查看作者发表的文章您也可以在PubMed Google Scholar中搜索该作者通讯作者:Wei J. Chen.Open Access 本文采用知识共享署名 4.0 国际许可协议进行许可,该协议允许以任何媒介或格式使用、共享、改编、分发和复制,只要您适当注明原作者和来源,提供知识共享许可协议的链接,并说明是否进行了修改。本文中的图片或其他第三方材料均包含在文章的知识共享许可协议中,除非在材料的署名栏中另有说明。如果材料未包含在文章的知识共享许可协议中,且您打算使用的材料不符合法律规定或超出许可使用范围,您需要直接从版权所有者处获得许可。要查看该许可的副本,请访问 http://creativecommons.org/licenses/by/4.0/。除非在数据的信用行中另有说明,否则知识共享公共领域专用免责声明(http://creativecommons.org/publicdomain/zero/1.0/)适用于本文提供的数据。转载与许可引用本文Chung, YC.E., Tung, YC., Wang, SC. et al. Correction:台湾美沙酮维持治疗门诊公共经费对减少参与人数和提高保留率的影响评估:间断时间序列分析。Implementation Sci 19, 28 (2024). https://doi.org/10.1186/s13012-024-01358-8Download citationPublished: 19 March 2024DOI: https://doi.org/10.1186/s13012-024-01358-8Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
{"title":"Correction: Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis","authors":"Yu-Chu Ella Chung, Yu-Chi Tung, Sheng-Chang Wang, Chieh-Liang Huang, Lian-Yu Chen, Wei J. Chen","doi":"10.1186/s13012-024-01358-8","DOIUrl":"https://doi.org/10.1186/s13012-024-01358-8","url":null,"abstract":"&lt;p&gt;&lt;b&gt;Correction&lt;/b&gt;&lt;b&gt;: &lt;/b&gt;&lt;b&gt;Implement Sci 19, 18 (2024)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;https://doi.org/10.1186/s13012-024-01351-1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Following the publication of the original article [1], the authors reported errors in Figure 1 and in a line of Page 3. In the original article, Figure 1 is shown as below.&lt;/p&gt;&lt;figure&gt;&lt;picture&gt;&lt;source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figa_HTML.png?as=webp\" type=\"image/webp\"/&gt;&lt;img alt=\"figure a\" aria-describedby=\"Figa\" height=\"632\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figa_HTML.png\" width=\"685\"/&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;There was an error with regard to the Large number (150-700); as it should have been (151-700).&lt;/p&gt;&lt;p&gt;Thus, the correct Figure 1 is shown below:&lt;/p&gt;&lt;figure&gt;&lt;picture&gt;&lt;source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figb_HTML.png?as=webp\" type=\"image/webp\"/&gt;&lt;img alt=\"figure b\" aria-describedby=\"Figb\" height=\"629\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13012-024-01358-8/MediaObjects/13012_2024_1358_Figb_HTML.png\" width=\"685\"/&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;Another error was also found on Page 3 of the Original Article. The second sentence of the second paragraph of the &lt;i&gt;Context of the MMT policy intervention&lt;/i&gt; section was read “For MMT clinics with larger capacities that were not eligible for the MCAM, we designated their scale as “large”, i.e., monthly average number of daily participants of 150 to 700.”&lt;/p&gt;&lt;p&gt;The correct sentence is: For MMT clinics with larger capacities that were not eligible for the MCAM, we designated their scale as “large”, i.e., monthly average number of daily participants of 151 to 700.&lt;/p&gt;&lt;p&gt;The original article [1] has been updated.&lt;/p&gt;&lt;ol data-track-component=\"outbound reference\"&gt;&lt;li data-counter=\"1.\"&gt;&lt;p&gt;Chung YCE, Tung YC, Wang SC, et al. Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis. Implement Sci. 2024;19:18. https://doi.org/10.1186/s13012-024-01351-1.&lt;/p&gt;&lt;p&gt;Article PubMed PubMed Central Google Scholar &lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Download references&lt;svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"&gt;&lt;use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/p&gt;&lt;h3&gt;Authors and Affiliations&lt;/h3&gt;&lt;ol&gt;&lt;li&gt;&lt;p&gt;Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan&lt;/p&gt;&lt;p&gt;Yu-Chu Ella Chung, Sheng-Chang Wang &amp; Wei J. Chen&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan&lt;/p&gt;&lt;p&gt;Yu-Chi Tung&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Tsaotun Psychiatric Center, Ministry of Health ","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"38 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140168849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generative AI in healthcare: an implementation science informed translational path on application, integration and governance. 医疗保健中的生成式人工智能:关于应用、整合和治理的实施科学转化路径。
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-15 DOI: 10.1186/s13012-024-01357-9
Sandeep Reddy
<p><strong>Background: </strong>Artificial intelligence (AI), particularly generative AI, has emerged as a transformative tool in healthcare, with the potential to revolutionize clinical decision-making and improve health outcomes. Generative AI, capable of generating new data such as text and images, holds promise in enhancing patient care, revolutionizing disease diagnosis and expanding treatment options. However, the utility and impact of generative AI in healthcare remain poorly understood, with concerns around ethical and medico-legal implications, integration into healthcare service delivery and workforce utilisation. Also, there is not a clear pathway to implement and integrate generative AI in healthcare delivery.</p><p><strong>Methods: </strong>This article aims to provide a comprehensive overview of the use of generative AI in healthcare, focusing on the utility of the technology in healthcare and its translational application highlighting the need for careful planning, execution and management of expectations in adopting generative AI in clinical medicine. Key considerations include factors such as data privacy, security and the irreplaceable role of clinicians' expertise. Frameworks like the technology acceptance model (TAM) and the Non-Adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) model are considered to promote responsible integration. These frameworks allow anticipating and proactively addressing barriers to adoption, facilitating stakeholder participation and responsibly transitioning care systems to harness generative AI's potential.</p><p><strong>Results: </strong>Generative AI has the potential to transform healthcare through automated systems, enhanced clinical decision-making and democratization of expertise with diagnostic support tools providing timely, personalized suggestions. Generative AI applications across billing, diagnosis, treatment and research can also make healthcare delivery more efficient, equitable and effective. However, integration of generative AI necessitates meticulous change management and risk mitigation strategies. Technological capabilities alone cannot shift complex care ecosystems overnight; rather, structured adoption programs grounded in implementation science are imperative.</p><p><strong>Conclusions: </strong>It is strongly argued in this article that generative AI can usher in tremendous healthcare progress, if introduced responsibly. Strategic adoption based on implementation science, incremental deployment and balanced messaging around opportunities versus limitations helps promote safe, ethical generative AI integration. Extensive real-world piloting and iteration aligned to clinical priorities should drive development. With conscientious governance centred on human wellbeing over technological novelty, generative AI can enhance accessibility, affordability and quality of care. As these models continue advancing rapidly, ongoing reassessment and transparent communicatio
背景:人工智能(AI),尤其是生成式人工智能,已成为医疗保健领域的一种变革性工具,具有彻底改变临床决策和改善健康结果的潜力。生成式人工智能能够生成文本和图像等新数据,有望加强患者护理、彻底改变疾病诊断和扩大治疗选择。然而,人们对生成式人工智能在医疗保健领域的效用和影响仍然知之甚少,对其伦理和医疗法律影响、与医疗保健服务提供的整合以及劳动力利用等方面存在担忧。此外,在医疗保健服务中实施和整合生成式人工智能还没有明确的途径:本文旨在全面概述生成式人工智能在医疗保健领域的应用,重点关注该技术在医疗保健领域的实用性及其转化应用,强调在临床医学中采用生成式人工智能时需要仔细规划、执行和管理预期。主要考虑因素包括数据隐私、安全性和临床医生专业知识的不可替代作用等。技术接受模型(TAM)和非采用、放弃、推广、普及和可持续性(NASSS)模型等框架被认为是促进负责任整合的方法。这些框架可以预测并主动解决采用障碍,促进利益相关者的参与,并以负责任的方式使护理系统过渡到利用生成式人工智能的潜力:通过自动化系统、强化临床决策和专业知识民主化,以及诊断支持工具提供及时、个性化的建议,生成式人工智能有可能改变医疗保健。生成式人工智能在计费、诊断、治疗和研究方面的应用也能使医疗服务更加高效、公平和有效。然而,要整合生成式人工智能,就必须制定细致的变革管理和风险缓解战略。仅靠技术能力无法在一夜之间改变复杂的医疗生态系统;相反,以实施科学为基础的结构化采用计划势在必行:本文有力地论证了,如果以负责任的方式引入人工智能,将为医疗保健带来巨大的进步。以实施科学为基础的战略性采用、渐进式部署以及围绕机遇与限制的平衡信息传递,有助于促进安全、合乎道德的生成式人工智能整合。应根据临床优先事项进行广泛的实际试点和迭代,以推动发展。通过以人类福祉而非技术新颖性为中心的有意识治理,人工智能生成技术可以提高医疗服务的可及性、可负担性和质量。随着这些模式的不断快速发展,围绕其优缺点进行持续的重新评估和透明的沟通对于恢复信任、实现积极的潜力,以及最重要的是改善患者的治疗效果仍然至关重要。
{"title":"Generative AI in healthcare: an implementation science informed translational path on application, integration and governance.","authors":"Sandeep Reddy","doi":"10.1186/s13012-024-01357-9","DOIUrl":"10.1186/s13012-024-01357-9","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Artificial intelligence (AI), particularly generative AI, has emerged as a transformative tool in healthcare, with the potential to revolutionize clinical decision-making and improve health outcomes. Generative AI, capable of generating new data such as text and images, holds promise in enhancing patient care, revolutionizing disease diagnosis and expanding treatment options. However, the utility and impact of generative AI in healthcare remain poorly understood, with concerns around ethical and medico-legal implications, integration into healthcare service delivery and workforce utilisation. Also, there is not a clear pathway to implement and integrate generative AI in healthcare delivery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This article aims to provide a comprehensive overview of the use of generative AI in healthcare, focusing on the utility of the technology in healthcare and its translational application highlighting the need for careful planning, execution and management of expectations in adopting generative AI in clinical medicine. Key considerations include factors such as data privacy, security and the irreplaceable role of clinicians' expertise. Frameworks like the technology acceptance model (TAM) and the Non-Adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) model are considered to promote responsible integration. These frameworks allow anticipating and proactively addressing barriers to adoption, facilitating stakeholder participation and responsibly transitioning care systems to harness generative AI's potential.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Generative AI has the potential to transform healthcare through automated systems, enhanced clinical decision-making and democratization of expertise with diagnostic support tools providing timely, personalized suggestions. Generative AI applications across billing, diagnosis, treatment and research can also make healthcare delivery more efficient, equitable and effective. However, integration of generative AI necessitates meticulous change management and risk mitigation strategies. Technological capabilities alone cannot shift complex care ecosystems overnight; rather, structured adoption programs grounded in implementation science are imperative.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;It is strongly argued in this article that generative AI can usher in tremendous healthcare progress, if introduced responsibly. Strategic adoption based on implementation science, incremental deployment and balanced messaging around opportunities versus limitations helps promote safe, ethical generative AI integration. Extensive real-world piloting and iteration aligned to clinical priorities should drive development. With conscientious governance centred on human wellbeing over technological novelty, generative AI can enhance accessibility, affordability and quality of care. As these models continue advancing rapidly, ongoing reassessment and transparent communicatio","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"19 1","pages":"27"},"PeriodicalIF":7.2,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10941464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140141169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the field of implementation science towards maturity: challenges and opportunities. 引导实施科学领域走向成熟:挑战与机遇。
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-13 DOI: 10.1186/s13012-024-01352-0
David A Chambers, Karen M Emmons

Background: The field of implementation science has significantly expanded in size and scope over the past two decades, although work related to understanding implementation processes have of course long preceded the more systematic efforts to improve integration of evidence-based interventions into practice settings. While this growth has had significant benefits to research, practice, and policy, there are some clear challenges that this period of adolescence has uncovered.

Main body: This invited commentary reflects on the development of implementation science, its rapid growth, and milestones in its establishment as a viable component of the biomedical research enterprise. The authors reflect on progress in research and training, and then unpack some of the consequences of rapid growth, as the field has grappled with the competing challenges of legitimacy among the research community set against the necessary integration and engagement with practice and policy partners. The article then enumerates a set of principles for the field's next developmental stage and espouses the aspirational goal of a "big tent" to support the next generation of impactful science.

Conclusion: For implementation science to expand its relevance and impact to practice and policy, researchers must not lose sight of the original purpose of the field-to support improvements in health and health care at scale, the importance of building a community of research and practice among key partners, and the balance of rigor, relevance, and societal benefit.

背景:在过去的二十年里,实施科学领域的规模和范围都有了显著的扩大,当然,与了解实施过程相关的工作早在将循证干预措施更好地融入实践环境的系统性工作之前就已经开始了。虽然这种增长对研究、实践和政策都有重大益处,但这一青春期也发现了一些明显的挑战:这篇特约评论回顾了实施科学的发展、其快速增长以及将其确立为生物医学研究事业可行组成部分的里程碑。作者对研究和培训方面的进展进行了反思,然后阐述了快速发展所带来的一些后果,因为该领域一直在努力应对研究界的合法性挑战,以及与实践和政策合作伙伴进行必要整合和接触的挑战。文章随后列举了该领域下一个发展阶段的一系列原则,并提出了 "大帐篷 "的理想目标,以支持下一代有影响力的科学:要想扩大实施科学对实践和政策的相关性和影响,研究人员就不能忽视该领域的初衷--支持大规模改善健康和医疗保健;不能忽视在主要合作伙伴之间建立研究和实践社区的重要性;不能忽视严谨性、相关性和社会效益之间的平衡。
{"title":"Navigating the field of implementation science towards maturity: challenges and opportunities.","authors":"David A Chambers, Karen M Emmons","doi":"10.1186/s13012-024-01352-0","DOIUrl":"10.1186/s13012-024-01352-0","url":null,"abstract":"<p><strong>Background: </strong>The field of implementation science has significantly expanded in size and scope over the past two decades, although work related to understanding implementation processes have of course long preceded the more systematic efforts to improve integration of evidence-based interventions into practice settings. While this growth has had significant benefits to research, practice, and policy, there are some clear challenges that this period of adolescence has uncovered.</p><p><strong>Main body: </strong>This invited commentary reflects on the development of implementation science, its rapid growth, and milestones in its establishment as a viable component of the biomedical research enterprise. The authors reflect on progress in research and training, and then unpack some of the consequences of rapid growth, as the field has grappled with the competing challenges of legitimacy among the research community set against the necessary integration and engagement with practice and policy partners. The article then enumerates a set of principles for the field's next developmental stage and espouses the aspirational goal of a \"big tent\" to support the next generation of impactful science.</p><p><strong>Conclusion: </strong>For implementation science to expand its relevance and impact to practice and policy, researchers must not lose sight of the original purpose of the field-to support improvements in health and health care at scale, the importance of building a community of research and practice among key partners, and the balance of rigor, relevance, and societal benefit.</p>","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"19 1","pages":"26"},"PeriodicalIF":7.2,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10936041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria 通过整合筛查和治疗服务加快消除宫颈癌(ACCESS 研究)实施战略的比较效果:尼日利亚分组随机混合 III 型试验方案
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-11 DOI: 10.1186/s13012-024-01349-9
Babayemi O. Olakunde, Ijeoma U. Itanyi, John O. Olawepo, Lin Liu, Chinenye Bembir, Ngozi Idemili-Aronu, Nwamaka N. Lasebikan, Tonia C. Onyeka, Cyril C. Dim, Chibuike O. Chigbu, Echezona E. Ezeanolue, Gregory A. Aarons
Despite the increased risk of cervical cancer (CC) among women living with HIV (WLHIV), CC screening and treatment (CCST) rates remain low in Africa. The integration of CCST services into established HIV programs in Africa can improve CC prevention and control. However, the paucity of evidence on effective implementation strategies (IS) has limited the success of integration in many countries. In this study, we seek to identify effective IS to enhance the integration of CCST services into existing HIV programs in Nigeria. Our proposed study has formative and experimental activities across the four phases of the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework. Through an implementation mapping conducted with stakeholders in the exploration phase, we identified a core package of IS (Core) and an enhanced package of IS (Core+) mostly selected from the Expert Recommendations for Implementing Change. In the preparation phase, we refined and tailored the Core and Core+ IS with the implementation resource teams for local appropriateness. In the implementation phase, we will conduct a cluster-randomized hybrid type III trial to assess the comparative effectiveness of Core versus Core+. HIV comprehensive treatment sites (k = 12) will be matched by region and randomized to Core or Core+ in the ratio of 1:1 stratified by region. In the sustainment phase, we will assess the sustainment of CCST at each site. The study outcomes will be assessed using RE-AIM: reach (screening rate), adoption (uptake of IS by study sites), IS fidelity (degree to which the IS occurred according to protocol), clinical intervention fidelity (delivery of CC screening, onsite treatment, and referral according to protocol), clinical effectiveness (posttreatment screen negative), and sustainment (continued integrated CCST service delivery). Additionally, we will descriptively explore potential mechanisms, including organizational readiness, implementation climate, CCST self-efficacy, and implementation intentions. The assessment of IS to increase CCST rates is consistent with the global plan of eliminating CC as a public health threat by 2030. Our study will identify a set of evidence-based IS for low-income settings to integrate evidence-based CCST interventions into routine HIV care in order to improve the health and life expectancy of WLHIV. Prospectively registered on November 7, 2023, at ClinicalTrials.gov no. NCT06128304. https://classic.clinicaltrials.gov/ct2/show/study/NCT06128304
尽管感染艾滋病毒的妇女(WLHIV)罹患宫颈癌(CC)的风险增加,但非洲的宫颈癌筛查和治疗(CCST)率仍然很低。将宫颈癌筛查和治疗服务纳入非洲既有的艾滋病项目可改善宫颈癌的预防和控制。然而,由于缺乏有效实施策略(IS)的证据,限制了许多国家整合工作的成功。在本研究中,我们试图找出有效的实施策略,以加强将 CCST 服务纳入尼日利亚现有的艾滋病项目。我们建议的研究在探索、准备、实施和维持(EPIS)框架的四个阶段开展形成性和实验性活动。在探索阶段,我们通过与利益相关者共同绘制实施图,确定了一套核心 IS(核心)和一套增强型 IS(核心+),其中大部分选自《实施变革的专家建议》。在准备阶段,我们与实施资源团队一起改进和调整了核心和核心+ IS,使之适合当地情况。在实施阶段,我们将进行分组随机混合 III 型试验,以评估 Core 与 Core+ 的比较效果。艾滋病毒综合治疗点(k = 12)将按地区进行匹配,并按地区分层,以 1:1 的比例随机分配到 Core 或 Core+。在持续阶段,我们将评估每个治疗点持续开展 CCST 的情况。研究结果将采用 RE-AIM 进行评估:覆盖率(筛查率)、采用率(研究机构对 IS 的接受程度)、IS 忠实度(IS 按照协议进行的程度)、临床干预忠实度(按照协议提供 CC 筛查、现场治疗和转诊)、临床效果(治疗后筛查阴性)和持续性(持续提供 CCST 综合服务)。此外,我们还将对潜在机制进行描述性探索,包括组织准备、实施氛围、CCST 自我效能和实施意图。对提高 CCST 使用率的信息系统进行评估符合到 2030 年消除 CC 这一公共卫生威胁的全球计划。我们的研究将为低收入环境确定一套循证IS,以便将循证CCST干预措施纳入常规艾滋病护理中,从而改善WLHIV的健康状况和预期寿命。该研究于 2023 年 11 月 7 日在 ClinicalTrials.gov 进行了前瞻性注册,注册号为 NCT06128304。NCT06128304. https://classic.clinicaltrials.gov/ct2/show/study/NCT06128304
{"title":"Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria","authors":"Babayemi O. Olakunde, Ijeoma U. Itanyi, John O. Olawepo, Lin Liu, Chinenye Bembir, Ngozi Idemili-Aronu, Nwamaka N. Lasebikan, Tonia C. Onyeka, Cyril C. Dim, Chibuike O. Chigbu, Echezona E. Ezeanolue, Gregory A. Aarons","doi":"10.1186/s13012-024-01349-9","DOIUrl":"https://doi.org/10.1186/s13012-024-01349-9","url":null,"abstract":"Despite the increased risk of cervical cancer (CC) among women living with HIV (WLHIV), CC screening and treatment (CCST) rates remain low in Africa. The integration of CCST services into established HIV programs in Africa can improve CC prevention and control. However, the paucity of evidence on effective implementation strategies (IS) has limited the success of integration in many countries. In this study, we seek to identify effective IS to enhance the integration of CCST services into existing HIV programs in Nigeria. Our proposed study has formative and experimental activities across the four phases of the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework. Through an implementation mapping conducted with stakeholders in the exploration phase, we identified a core package of IS (Core) and an enhanced package of IS (Core+) mostly selected from the Expert Recommendations for Implementing Change. In the preparation phase, we refined and tailored the Core and Core+ IS with the implementation resource teams for local appropriateness. In the implementation phase, we will conduct a cluster-randomized hybrid type III trial to assess the comparative effectiveness of Core versus Core+. HIV comprehensive treatment sites (k = 12) will be matched by region and randomized to Core or Core+ in the ratio of 1:1 stratified by region. In the sustainment phase, we will assess the sustainment of CCST at each site. The study outcomes will be assessed using RE-AIM: reach (screening rate), adoption (uptake of IS by study sites), IS fidelity (degree to which the IS occurred according to protocol), clinical intervention fidelity (delivery of CC screening, onsite treatment, and referral according to protocol), clinical effectiveness (posttreatment screen negative), and sustainment (continued integrated CCST service delivery). Additionally, we will descriptively explore potential mechanisms, including organizational readiness, implementation climate, CCST self-efficacy, and implementation intentions. The assessment of IS to increase CCST rates is consistent with the global plan of eliminating CC as a public health threat by 2030. Our study will identify a set of evidence-based IS for low-income settings to integrate evidence-based CCST interventions into routine HIV care in order to improve the health and life expectancy of WLHIV. Prospectively registered on November 7, 2023, at ClinicalTrials.gov no. NCT06128304. https://classic.clinicaltrials.gov/ct2/show/study/NCT06128304 ","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"66 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140097696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE): protocol for a helix-counterbalanced randomised controlled trial 居家养老院循证用药知识经纪人(EMBRACE):螺旋平衡随机对照试验方案
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-04 DOI: 10.1186/s13012-024-01353-z
J. Simon Bell, Adam La Caze, Michelle Steeper, Terry P. Haines, Sarah N. Hilmer, Lakkhina Troeung, Lyntara Quirke, Jacqueline Wesson, Constance Dimity Pond, Laurie Buys, Nazanin Ghahreman-Falconer, Michael T. Lawless, Shakti Shrestha, Angelita Martini, Nancy Ochieng, Francesca Glamorgan, Carmela Lagasca, Rebecca Walton, Dayna Cenin, Alison Kitson, Monica Jung, Alexandra Bennett, Amanda J. Cross
Clinical practice guidelines recommend against the routine use of psychotropic medications in residential aged care facilities (RACFs). Knowledge brokers are individuals or groups who facilitate the transfer of knowledge into practice. The objective of this trial is to evaluate the effectiveness and cost-effectiveness of using knowledge brokers to translate Australia’s new Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care. The Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE) trial is a helix-counterbalanced randomised controlled trial. The 12-month trial will be conducted in up to 19 RACFs operated by four Australian aged care provider organisations in Victoria, New South Wales, Western Australia and Queensland. RACFs will be randomised to receive three levels of implementation strategies (knowledge broker service, pharmacist-led quality use of medications education activities and distribution of the Guidelines and supporting materials) across three medication contexts (antipsychotics, benzodiazepines and antidepressants). Implementation strategies will be delivered by an embedded on-site aged care pharmacist working at a system level across each participating RACF. All RACFs will receive all implementation strategies simultaneously but for different medication contexts. The primary outcome will be a composite dichotomous measure of 6-month RACF-level concordance with Guideline recommendations and good practice statements among people using antipsychotics, benzodiazepines and antidepressants for changed behaviours. Secondary outcomes will include proportion of residents with Guideline concordant use of antipsychotics, benzodiazepines and antidepressants measured at the RACF-level and proportion of residents with psychotropic medication use, hospitalisation, falls, falls with injury, polypharmacy, quality of life, activities of daily living, medication incidents and behavioural incidents measured at the RACF-level. The EMBRACE trial investigates a novel guideline implementation strategy to improve the safe and effective use of psychotropic medications in RACFs. We anticipate that the findings will provide new information on the potential role of knowledge brokers for successful and cost-effective guideline implementation. Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12623001141639. Registered 6 November 2023 — retrospectively registered, https://www.anzctr.org.au/TrialSearch.aspx .
临床实践指南建议不要在养老院中常规使用精神药物。知识经纪人是促进将知识转化为实践的个人或团体。本试验旨在评估使用知识经纪人将澳大利亚新版《老年痴呆症患者和老年护理机构精神药物合理使用临床实践指南》转化为实践的有效性和成本效益。养老院循证用药知识经纪人(EMBRACE)试验是一项螺旋平衡随机对照试验。这项为期 12 个月的试验将在维多利亚州、新南威尔士州、西澳大利亚州和昆士兰州由四家澳大利亚老年护理提供机构运营的多达 19 家老年护理中心进行。养老护理中心将随机接受三种用药环境(抗精神病药物、苯二氮卓类药物和抗抑郁药物)下的三个级别的实施策略(知识中介服务、药剂师主导的药物使用质量教育活动以及《指南》和辅助材料的分发)。实施策略将由一名嵌入式现场老年护理药剂师在系统层面为每个参与的 RACF 提供服务。所有 RACF 将同时接受所有实施策略,但针对不同的用药情况。主要结果是对使用抗精神病药物、苯二氮卓类药物和抗抑郁药物来改变行为的患者在 6 个月的 RACF 水平上与《指南》建议和良好实践声明的一致性进行综合二分法测量。次要结果将包括:在 RACF 层面测量抗精神病药物、苯二氮卓类药物和抗抑郁药物使用与《指南》一致的住院患者比例,以及在 RACF 层面测量精神药物使用、住院、跌倒、跌倒致伤、多药治疗、生活质量、日常生活活动、用药事故和行为事故的住院患者比例。EMBRACE 试验研究了一种新的指南实施策略,以提高精神药物在 RACF 中的安全有效使用。我们预计,研究结果将为知识经纪人在成功实施具有成本效益的指南方面可能发挥的作用提供新的信息。澳大利亚-新西兰临床试验注册中心(ANZCTR):ACTRN12623001141639。2023 年 11 月 6 日注册 - 追溯注册,https://www.anzctr.org.au/TrialSearch.aspx 。
{"title":"Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE): protocol for a helix-counterbalanced randomised controlled trial","authors":"J. Simon Bell, Adam La Caze, Michelle Steeper, Terry P. Haines, Sarah N. Hilmer, Lakkhina Troeung, Lyntara Quirke, Jacqueline Wesson, Constance Dimity Pond, Laurie Buys, Nazanin Ghahreman-Falconer, Michael T. Lawless, Shakti Shrestha, Angelita Martini, Nancy Ochieng, Francesca Glamorgan, Carmela Lagasca, Rebecca Walton, Dayna Cenin, Alison Kitson, Monica Jung, Alexandra Bennett, Amanda J. Cross","doi":"10.1186/s13012-024-01353-z","DOIUrl":"https://doi.org/10.1186/s13012-024-01353-z","url":null,"abstract":"Clinical practice guidelines recommend against the routine use of psychotropic medications in residential aged care facilities (RACFs). Knowledge brokers are individuals or groups who facilitate the transfer of knowledge into practice. The objective of this trial is to evaluate the effectiveness and cost-effectiveness of using knowledge brokers to translate Australia’s new Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care. The Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE) trial is a helix-counterbalanced randomised controlled trial. The 12-month trial will be conducted in up to 19 RACFs operated by four Australian aged care provider organisations in Victoria, New South Wales, Western Australia and Queensland. RACFs will be randomised to receive three levels of implementation strategies (knowledge broker service, pharmacist-led quality use of medications education activities and distribution of the Guidelines and supporting materials) across three medication contexts (antipsychotics, benzodiazepines and antidepressants). Implementation strategies will be delivered by an embedded on-site aged care pharmacist working at a system level across each participating RACF. All RACFs will receive all implementation strategies simultaneously but for different medication contexts. The primary outcome will be a composite dichotomous measure of 6-month RACF-level concordance with Guideline recommendations and good practice statements among people using antipsychotics, benzodiazepines and antidepressants for changed behaviours. Secondary outcomes will include proportion of residents with Guideline concordant use of antipsychotics, benzodiazepines and antidepressants measured at the RACF-level and proportion of residents with psychotropic medication use, hospitalisation, falls, falls with injury, polypharmacy, quality of life, activities of daily living, medication incidents and behavioural incidents measured at the RACF-level. The EMBRACE trial investigates a novel guideline implementation strategy to improve the safe and effective use of psychotropic medications in RACFs. We anticipate that the findings will provide new information on the potential role of knowledge brokers for successful and cost-effective guideline implementation. Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12623001141639. Registered 6 November 2023 — retrospectively registered, https://www.anzctr.org.au/TrialSearch.aspx .","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"40 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140026055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol for a parallel cluster randomized trial of a participatory tailored approach to reduce overuse of antibiotics at hospital discharge: the ROAD home trial 减少出院时过度使用抗生素的参与式定制方法平行分组随机试验方案:ROAD home 试验
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-03-04 DOI: 10.1186/s13012-024-01348-w
Julia E. Szymczak, Lindsay A. Petty, Tejal N. Gandhi, Robert A. Neetz, Adam Hersh, Angela P. Presson, Peter K. Lindenauer, Steven J. Bernstein, Brandi M. Muller, Andrea T. White, Jennifer K. Horowitz, Scott A. Flanders, Justin D. Smith, Valerie M. Vaughn
Antibiotic overuse at hospital discharge is common, costly, and harmful. While discharge-specific antibiotic stewardship interventions are effective, they are resource-intensive and often infeasible for hospitals with resource constraints. This weakness impacts generalizability of stewardship interventions and has health equity implications as not all patients have access to the benefits of stewardship based on where they receive care. There may be different pathways to improve discharge antibiotic prescribing that vary widely in feasibility. Supporting hospitals in selecting interventions tailored to their context may be an effective approach to feasibly reduce antibiotic overuse at discharge across diverse hospitals. The objective of this study is to evaluate the effectiveness of the Reducing Overuse of Antibiotics at Discharge Home multicomponent implementation strategy (“ROAD Home”) on antibiotic overuse at discharge for community-acquired pneumonia and urinary tract infection. This 4-year two-arm parallel cluster-randomized trial will include three phases: baseline (23 months), intervention (12 months), and postintervention (12 months). Forty hospitals recruited from the Michigan Hospital Medicine Safety Consortium will undergo covariate-constrained randomization with half randomized to the ROAD Home implementation strategy and half to a “stewardship as usual” control. ROAD Home is informed by the integrated-Promoting Action on Research Implementation in Health Services Framework and includes (1) a baseline needs assessment to create a tailored suite of potential stewardship interventions, (2) supported decision-making in selecting interventions to implement, and (3) external facilitation following an implementation blueprint. The primary outcome is baseline-adjusted days of antibiotic overuse at discharge. Secondary outcomes include 30-day patient outcomes and antibiotic-associated adverse events. A mixed-methods concurrent process evaluation will identify contextual factors influencing the implementation of tailored interventions, and assess implementation outcomes including acceptability, feasibility, fidelity, and sustainment. Reducing antibiotic overuse at discharge across hospitals with varied resources requires tailoring of interventions. This trial will assess whether a multicomponent implementation strategy that supports hospitals in selecting evidence-based stewardship interventions tailored to local context leads to reduced overuse of antibiotics at discharge. Knowledge gained during this study could inform future efforts to implement stewardship in diverse hospitals and promote equity in access to the benefits of quality improvement initiatives. Clinicaltrials.gov NCT06106204 on 10/30/23
出院时过度使用抗生素的现象十分普遍,成本高昂且有害。虽然针对出院的抗生素监管干预措施很有效,但这些措施需要大量资源,对于资源有限的医院来说往往不可行。这一弱点影响了监管干预措施的普及性,并对健康公平产生了影响,因为并非所有患者都能根据其接受治疗的地点获得监管措施的益处。改善出院抗生素处方可能有不同的途径,其可行性也大相径庭。支持医院选择适合其具体情况的干预措施可能是一种有效的方法,可在不同医院中切实减少出院时抗生素的过度使用。本研究旨在评估 "减少出院时抗生素过度使用家庭"(Reducing Overuse of Antibiotics at Discharge Home)多组分实施策略("ROAD Home")对社区获得性肺炎和尿路感染患者出院时抗生素过度使用的效果。这项为期 4 年的双臂平行分组随机试验将包括三个阶段:基线(23 个月)、干预(12 个月)和干预后(12 个月)。从密歇根州医院医疗安全联盟(Michigan Hospital Medicine Safety Consortium)招募的 40 家医院将进行协变量约束随机分配,一半医院被随机分配到 ROAD Home 实施策略中,另一半医院被随机分配到 "管理如常 "对照组中。ROAD Home 以 "促进医疗服务研究实施行动 "综合框架为指导,包括:(1)基线需求评估,以创建一套量身定制的潜在监管干预措施;(2)在选择实施干预措施时进行辅助决策;(3)按照实施蓝图进行外部促进。主要结果是出院时抗生素过度使用的基线调整天数。次要结果包括 30 天的患者疗效和抗生素相关不良事件。混合方法并行过程评估将确定影响定制干预措施实施的背景因素,并评估包括可接受性、可行性、忠实性和持续性在内的实施结果。不同医院的资源各不相同,要减少出院时抗生素的过度使用,就需要量身定制干预措施。本试验将评估一项多成分实施策略是否能帮助医院根据当地情况选择循证管理干预措施,从而减少出院时抗生素的过度使用。这项研究中获得的知识可为今后在不同医院实施监管措施提供参考,并促进公平享受质量改进措施带来的益处。Clinicaltrials.gov NCT06106204 on 10/30/23
{"title":"Protocol for a parallel cluster randomized trial of a participatory tailored approach to reduce overuse of antibiotics at hospital discharge: the ROAD home trial","authors":"Julia E. Szymczak, Lindsay A. Petty, Tejal N. Gandhi, Robert A. Neetz, Adam Hersh, Angela P. Presson, Peter K. Lindenauer, Steven J. Bernstein, Brandi M. Muller, Andrea T. White, Jennifer K. Horowitz, Scott A. Flanders, Justin D. Smith, Valerie M. Vaughn","doi":"10.1186/s13012-024-01348-w","DOIUrl":"https://doi.org/10.1186/s13012-024-01348-w","url":null,"abstract":"Antibiotic overuse at hospital discharge is common, costly, and harmful. While discharge-specific antibiotic stewardship interventions are effective, they are resource-intensive and often infeasible for hospitals with resource constraints. This weakness impacts generalizability of stewardship interventions and has health equity implications as not all patients have access to the benefits of stewardship based on where they receive care. There may be different pathways to improve discharge antibiotic prescribing that vary widely in feasibility. Supporting hospitals in selecting interventions tailored to their context may be an effective approach to feasibly reduce antibiotic overuse at discharge across diverse hospitals. The objective of this study is to evaluate the effectiveness of the Reducing Overuse of Antibiotics at Discharge Home multicomponent implementation strategy (“ROAD Home”) on antibiotic overuse at discharge for community-acquired pneumonia and urinary tract infection. This 4-year two-arm parallel cluster-randomized trial will include three phases: baseline (23 months), intervention (12 months), and postintervention (12 months). Forty hospitals recruited from the Michigan Hospital Medicine Safety Consortium will undergo covariate-constrained randomization with half randomized to the ROAD Home implementation strategy and half to a “stewardship as usual” control. ROAD Home is informed by the integrated-Promoting Action on Research Implementation in Health Services Framework and includes (1) a baseline needs assessment to create a tailored suite of potential stewardship interventions, (2) supported decision-making in selecting interventions to implement, and (3) external facilitation following an implementation blueprint. The primary outcome is baseline-adjusted days of antibiotic overuse at discharge. Secondary outcomes include 30-day patient outcomes and antibiotic-associated adverse events. A mixed-methods concurrent process evaluation will identify contextual factors influencing the implementation of tailored interventions, and assess implementation outcomes including acceptability, feasibility, fidelity, and sustainment. Reducing antibiotic overuse at discharge across hospitals with varied resources requires tailoring of interventions. This trial will assess whether a multicomponent implementation strategy that supports hospitals in selecting evidence-based stewardship interventions tailored to local context leads to reduced overuse of antibiotics at discharge. Knowledge gained during this study could inform future efforts to implement stewardship in diverse hospitals and promote equity in access to the benefits of quality improvement initiatives. Clinicaltrials.gov NCT06106204 on 10/30/23","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"30 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140026058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial. 组织和动员以提高注射器服务计划的用药过量教育和纳洛酮分配的实施效果:随机对照试验。
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-02-28 DOI: 10.1186/s13012-024-01354-y
Barrot H Lambdin, Ricky N Bluthenthal, Bryan R Garner, Lynn D Wenger, Erica N Browne, Terry Morris, Lee Ongais, Cariné E Megerian, Alex H Kral

Background: The United States (US) continues to face decades-long increases in opioid overdose fatalities. As an opioid overdose reversal medication, naloxone can dramatically reduce opioid overdose mortality rates when distributed to people likely to experience or witness an opioid overdose and packaged with education on its use, known as overdose education and naloxone distribution (OEND). Syringe services programs (SSPs) are ideal venues for OEND with staff who are culturally competent in providing services for people who are at risk of experiencing or observing an opioid overdose. We carried out a randomized controlled trial of SSPs to understand the effectiveness of the organize and mobilize for implementation effectiveness (OMIE) approach at improving OEND implementation effectiveness within SSPs.

Methods: Using simple randomization, 105 SSPs were enrolled into the trial and assigned to one of two study arms - (1) dissemination of OEND best practice recommendations (Control SSPs) or the OMIE approach along with dissemination of the OEND best practice recommendations (i.e., OMIE SSPs). OMIE SSPs could participate in 60-min OMIE sessions once a month for up to 12 months. At 12-month post-baseline, 102 of 105 SSPs (97%) responded to the follow-up survey.

Results: The median number of sessions completed by OMIE SSPs was 10. Comparing OMIE SSPs to control SSPs, we observed significant increases in the number of participants receiving naloxone (incidence rate ratio: 2.15; 95% CI: 1.42, 3.25; p < 0.01) and the rate of naloxone doses distributed per SSP participant (adjusted incidence rate ratio: 1.97; 95% CI: 1.18, 3.30; p = 0.01). We observed no statistically significant difference in the number of adopted best practices between conditions (difference in means 0.2, 95% CI: - 0.7, 1.0; p = 0.68). We also observed a threshold effect where SSPs receiving a higher OMIE dose had greater effect sizes with regard to the number of people given naloxone and the number of naloxone doses distributed.

Conclusions: In conclusion, the multifaceted OMIE approach was effective at increasing naloxone distribution from SSPs, despite substantial external shocks during the trial. These findings have major implications for addressing the overdose crisis, which has continued unabated for decades.

Trial registration: ClinicalTrials.gov, NCT03924505 . Registered 19 April 2019.

背景:数十年来,美国阿片类药物过量致死率持续上升。纳洛酮作为一种阿片类药物过量逆转药物,如果将其发放给可能经历或目睹阿片类药物过量的人,并对其使用方法进行教育,就能显著降低阿片类药物过量死亡率,这就是所谓的过量教育和纳洛酮发放(OEND)。注射器服务计划(SSP)是开展过量教育和纳洛酮发放的理想场所,其工作人员在为可能或亲眼目睹阿片类药物过量的人群提供服务方面具有文化能力。我们对 SSP 进行了一项随机对照试验,以了解组织和动员实施有效性(OMIE)方法在提高 SSP 内 OEND 实施有效性方面的有效性:采用简单的随机化方法,105 个小规模学校被纳入试验,并被分配到两个研究臂中的一个--(1)传播 OEND 最佳实践建议(对照小规模学校)或在传播 OEND 最佳实践建议的同时采用 OMIE 方法(即 OMIE 小规模学校)。OMIE SSPs可每月参加一次60分钟的OMIE课程,最长持续12个月。在基线后的12个月,105名SSP中的102人(97%)回复了后续调查:OMIE服务提供者完成的课程次数中位数为10次。将OMIE SSPs与对照SSPs进行比较,我们发现接受纳洛酮治疗的参与者人数显著增加(发生率比:2.15;95% CI:1.42,3.25;P 结论:OMIE SSPs与对照SSPs相比,其疗效显著:总之,尽管在试验期间受到了巨大的外部冲击,但多方面的 OMIE 方法还是有效地增加了纳洛酮从 SSP 的分发量。这些研究结果对解决用药过量危机具有重要意义,几十年来,用药过量危机有增无减:试验注册:ClinicalTrials.gov, NCT03924505 。注册日期:2019 年 4 月 19 日。
{"title":"Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.","authors":"Barrot H Lambdin, Ricky N Bluthenthal, Bryan R Garner, Lynn D Wenger, Erica N Browne, Terry Morris, Lee Ongais, Cariné E Megerian, Alex H Kral","doi":"10.1186/s13012-024-01354-y","DOIUrl":"10.1186/s13012-024-01354-y","url":null,"abstract":"<p><strong>Background: </strong>The United States (US) continues to face decades-long increases in opioid overdose fatalities. As an opioid overdose reversal medication, naloxone can dramatically reduce opioid overdose mortality rates when distributed to people likely to experience or witness an opioid overdose and packaged with education on its use, known as overdose education and naloxone distribution (OEND). Syringe services programs (SSPs) are ideal venues for OEND with staff who are culturally competent in providing services for people who are at risk of experiencing or observing an opioid overdose. We carried out a randomized controlled trial of SSPs to understand the effectiveness of the organize and mobilize for implementation effectiveness (OMIE) approach at improving OEND implementation effectiveness within SSPs.</p><p><strong>Methods: </strong>Using simple randomization, 105 SSPs were enrolled into the trial and assigned to one of two study arms - (1) dissemination of OEND best practice recommendations (Control SSPs) or the OMIE approach along with dissemination of the OEND best practice recommendations (i.e., OMIE SSPs). OMIE SSPs could participate in 60-min OMIE sessions once a month for up to 12 months. At 12-month post-baseline, 102 of 105 SSPs (97%) responded to the follow-up survey.</p><p><strong>Results: </strong>The median number of sessions completed by OMIE SSPs was 10. Comparing OMIE SSPs to control SSPs, we observed significant increases in the number of participants receiving naloxone (incidence rate ratio: 2.15; 95% CI: 1.42, 3.25; p < 0.01) and the rate of naloxone doses distributed per SSP participant (adjusted incidence rate ratio: 1.97; 95% CI: 1.18, 3.30; p = 0.01). We observed no statistically significant difference in the number of adopted best practices between conditions (difference in means 0.2, 95% CI: - 0.7, 1.0; p = 0.68). We also observed a threshold effect where SSPs receiving a higher OMIE dose had greater effect sizes with regard to the number of people given naloxone and the number of naloxone doses distributed.</p><p><strong>Conclusions: </strong>In conclusion, the multifaceted OMIE approach was effective at increasing naloxone distribution from SSPs, despite substantial external shocks during the trial. These findings have major implications for addressing the overdose crisis, which has continued unabated for decades.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov, NCT03924505 . Registered 19 April 2019.</p>","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"19 1","pages":"22"},"PeriodicalIF":7.2,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation strategies in suicide prevention: a scoping review 预防自杀的实施策略:范围界定审查
IF 7.2 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-02-26 DOI: 10.1186/s13012-024-01350-2
Jason I. Chen, Brandon Roth, Steven K. Dobscha, Julie C. Lowery
Implementation strategies can be a vital leveraging point for enhancing the implementation and dissemination of evidence-based suicide prevention interventions and programming. However, much remains unknown about which implementation strategies are commonly used and effective for supporting suicide prevention efforts. In light of the limited available literature, a scoping review was conducted to evaluate implementation strategies present in current suicide prevention studies. We identified studies that were published between 2013 and 2022 that focused on suicide prevention and incorporated at least one implementation strategy. Studies were coded by two independent coders who showed strong inter-rater reliability. Data were synthesized using descriptive statistics and a narrative synthesis of findings. Overall, we found that studies most commonly utilized strategies related to iterative evaluation, training, and education. The majority of studies did not include direct measurement of suicide behavior outcomes, and there were few studies that directly tested implementation strategy effectiveness. Implementation science strategies remain an important component for improving suicide prevention and intervention implementation. Future research should consider the incorporation of more type 3 hybrid designs as well as increased systematic documentation of implementation strategies. < de-identified > 
实施策略是加强循证自杀预防干预措施和计划的实施与传播的重要杠杆。然而,对于哪些实施策略常用且能有效支持自杀预防工作,仍有许多未知数。鉴于现有文献有限,我们进行了一次范围界定审查,以评估当前自杀预防研究中存在的实施策略。我们确定了 2013 年至 2022 年间发表的研究,这些研究关注自杀预防并纳入了至少一种实施策略。研究由两名独立的编码员进行编码,他们的相互评分可靠性很高。我们使用描述性统计和研究结果的叙述性综述对数据进行了综合。总体而言,我们发现研究中最常采用的策略与迭代评估、培训和教育有关。大多数研究并不包括对自杀行为结果的直接测量,直接测试实施策略有效性的研究也很少。实施科学策略仍然是改进自杀预防和干预措施实施的重要组成部分。未来的研究应考虑纳入更多的第三类混合设计,并增加对实施策略的系统记录。
{"title":"Implementation strategies in suicide prevention: a scoping review","authors":"Jason I. Chen, Brandon Roth, Steven K. Dobscha, Julie C. Lowery","doi":"10.1186/s13012-024-01350-2","DOIUrl":"https://doi.org/10.1186/s13012-024-01350-2","url":null,"abstract":"Implementation strategies can be a vital leveraging point for enhancing the implementation and dissemination of evidence-based suicide prevention interventions and programming. However, much remains unknown about which implementation strategies are commonly used and effective for supporting suicide prevention efforts. In light of the limited available literature, a scoping review was conducted to evaluate implementation strategies present in current suicide prevention studies. We identified studies that were published between 2013 and 2022 that focused on suicide prevention and incorporated at least one implementation strategy. Studies were coded by two independent coders who showed strong inter-rater reliability. Data were synthesized using descriptive statistics and a narrative synthesis of findings. Overall, we found that studies most commonly utilized strategies related to iterative evaluation, training, and education. The majority of studies did not include direct measurement of suicide behavior outcomes, and there were few studies that directly tested implementation strategy effectiveness. Implementation science strategies remain an important component for improving suicide prevention and intervention implementation. Future research should consider the incorporation of more type 3 hybrid designs as well as increased systematic documentation of implementation strategies. < de-identified > ","PeriodicalId":54995,"journal":{"name":"Implementation Science","volume":"5 1","pages":""},"PeriodicalIF":7.2,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139969420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Implementation Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1